During the past decade, Aou Federico Ii - Napoli - Uoc Ematologia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aou Federico Ii - Napoli - Uoc Ematologia" #1 collaborator was "ERIC Group" with 1 trials as a collaborator and "Hematology Project Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Aou Federico Ii - Napoli - Uoc Ematologia" are "Acute Myeloid Leukemia" (2 trials), "Acute Lymphoblastic Leukemia, in Relapse" (1 trials), "Adults" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Lymphoid Leukemia" (1 trials). Many other conditions were trialed in "Aou Federico Ii - Napoli - Uoc Ematologia" in a lesser frequency.

Most popular intervention types in "Aou Federico Ii - Napoli - Uoc Ematologia" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ponatinib" (2 trials), "eculizumab" (2 trials), "Chemotherapy" (1 trials), "Gemtuzumab Ozogamicin" (1 trials) and "Glasdegib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aou Federico Ii - Napoli - Uoc Ematologia" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Aou Federico Ii - Napoli - Uoc Ematologia". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aou Federico Ii - Napoli - Uoc Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aou Federico Ii - Napoli - Uoc Ematologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".